Radiosensitization enhancement

The phrase "radiosensitization enhancement" refers broadly to any method or agent that augments the sensitivity of living tissues—most often cancer cells—to ionizing radiation. This is accomplished through a variety of mechanisms, including increasing oxidative stress, disrupting DNA repair, modulating cell cycle checkpoints, and influencing the tumor microenvironment. While many molecules (such as gold nanoparticles, platinum-based drugs, or other small chemicals) serve as radiosensitizers, "radiosensitization enhancement" itself is an effect or goal, not a discrete molecule or protein that can be directly targeted or classified. There is no single molecule, receptor, or gene named "Radiosensitization enhancement." Agents called radiosensitizers (such as certain nanoparticles, chemotherapeutics, or biologicals) are developed to achieve this enhancement—but "radiosensitization enhancement" is not itself a molecular drug target.

Radiosensitization enhancement is achieved through various cellular and molecular mechanisms, including but not limited to, increasing oxidative stress within cells, disrupting critical DNA repair pathways (e.g., homologous recombination, non-homologous end joining), modulating cell cycle checkpoints to trap cells in radiosensitive phases, inhibiting anti-apoptotic pathways, and favorably altering the tumor microenvironment (e.g., re-oxygenation, immune modulation) to make cancer cells more susceptible to radiation-induced damage.